title: Exposure to β-lactams results in the alteration of penicillin-binding proteins in Clostridium perfringens.
abstract: Clostridium perfringens causes a variety of mild to severe infections in humans and other animals. A decrease in the affinity of penicillin-binding protein (PBP) transpeptidases for β-lactams is considered one of the mechanisms of β-lactam resistance in bacteria. Two strains of C. perfringens isolated from bovines and one isolated from a chicken, which had decreased susceptibility to β-lactams, had variations in the amino acid sequences of the central penicillin-binding regions of the PBPs. β-Lactam-resistant mutants of another C. perfringens strain, ATCC 13124, were selected in vitro to determine the effects of exposure to β-lactams on the PBP genes. Cultures of the wild type rapidly developed resistance to penicillin G, cephalothin and ceftriaxone. The susceptibilities of all of the selected mutants to some other β-lactams also decreased. The largest PBP found in C. perfringens, CPF_2395, appeared to be the primary target of all three drugs. Strain resistant to penicillin G had mutation resulting in the substitution of one amino acid within the central penicillin-binding/transpeptidase domain, but the ceftrioxane and cephalothin-resistant strains had mutations resulting in the substitution of two amino acids in this region. The cephalothin-resistant mutant also had additional mutations in the CPF_0340 and CPF_2218 genes in this critical region. No other mutations were observed in the three other PBPs of the in vitro resistant mutants. Resistance development also altered the growth rate and cell morphology of the mutants, so in addition to the PBPs, some other genes, including regulatory genes, may have been affected during the interaction with β-lactam antibiotics. This is the first study showing the effects of β-lactam drugs on the substitution of amino acids in PBPs of C. perfringens and points to the need for studies to detect other unknown alterations affecting the physiology of resistant strains.
authors.affiliation: Division of Microbiology, National Center for Toxicological Research, FDA, Jefferson, AR 72079, USA.
authors.forename: Miseon
authors.initials: M
authors.lastname: Park
authors.affiliation: Division of Microbiology, National Center for Toxicological Research, FDA, Jefferson, AR 72079, USA. Electronic address: Fatemeh.rafii@fda.hhs.gov.
authors.forename: Fatemeh
authors.initials: F
authors.lastname: Rafii
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002417:Cattle; D002645:Chickens; D003015:Clostridium Infections / Q000382:microbiology / Q000662:veterinary; D003016:Clostridium perfringens / Q000187:drug effects* / Q000201:enzymology* / Q000302:isolation & purification; D004252:DNA Mutational Analysis; D020125:Mutation, Missense; D046915:Penicillin-Binding Proteins / Q000235:genetics*; D012641:Selection, Genetic; D018440:beta-Lactam Resistance; D047090:beta-Lactams / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D046915:Penicillin-Binding Proteins; D047090:beta-Lactams
keywords: Clostridium perfringens; Mutation; Penicillin-binding protein; Resistance; β-Lactam